54. PREDICTION OF ANTIPSYCHOTIC-INDUCED METABOLIC ADVERSE EFFECTS USING MULTIMODAL ARTIFICIAL INTELLIGENCE

Khushbu Agarwal, Ayman H. Fanous(University of Arizona), Colby Ham(Pacific Northwest National Laboratory), Silviu‐Alin Bacanu, Sutanay Choudhury, Ravi Madduri(Argonne National Laboratory), Philip D. Harvey(University of Miami), Benjamin McMahon(Los Alamos National Laboratory), Beauty Kolade(Los Alamos National Laboratory), Julie Kreyenbuhl(University of Maryland, Baltimore), Stephen R. Marder(West Los Angeles College), Hamed Abbaszadegan(Phoenix VA Health Care System), Alejandro Zuniga(Pacific Northwest National Laboratory), Sayera Dhaubhadel(Los Alamos National Laboratory)
European Neuropsychopharmacology
October 1, 2024
10.1016/j.euroneuro.2024.08.168
Cited by 1

Related Papers

Sparse whole-genome sequencing identifies two loci for major depressive disorder
|Nature|2015|922
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes
|Cell|2018|821
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|781
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
|Schizophrenia Bulletin|2004|768